Cargando…
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
Autores principales: | Tamura, Ryota, Fujioka, Masato, Morimoto, Yukina, Ohara, Kentaro, Kosugi, Kenzo, Oishi, Yumiko, Sato, Mizuto, Ueda, Ryo, Fujiwara, Hirokazu, Hikichi, Tetsuro, Noji, Shinobu, Oishi, Naoki, Ogawa, Kaoru, Kawakami, Yutaka, Ohira, Takayuki, Yoshida, Kazunari, Toda, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174327/ https://www.ncbi.nlm.nih.gov/pubmed/32317644 http://dx.doi.org/10.1038/s41467-020-16007-z |
Ejemplares similares
-
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2019) -
Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020) -
Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
por: Tamura, Ryota, et al.
Publicado: (2020) -
IMT-02 VEGF RECEPTORS EXPRESSION AND REPORT OF CLINICAL TRIAL OF PEPTIDE VACCINE IN SKULL BASE CHORDOMA
por: Morimoto, Yukina, et al.
Publicado: (2019) -
A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma
por: Tamura, Ryota, et al.
Publicado: (2020)